Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToNetincome,capitalExpenditures,changeToInventory,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,esgPopulated,tradeable,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,shortName,exchange,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,country,website,maxAge,address1,fax,industry,address2
t0,IGNE,-4904813,1565400064,527646,,-627236,,-627236,141526,0,-95441,-95441,-573731,-10234,,,,0,0,95441,0,-531795,,-627236,-627236,218959,34466645,7852791,-4685854,1612500,3412776,15654043,-54859011,5359299,52469,5125,269290,2129618,52469,746964,2441728,2172362,363874,517118,36638.0,-1.0,11072.0,-708091.0,2502.0,-710592.0,45380.0,-176445.0,,,,312110,en-US,US,EQUITY,False,Delayed Quote,-12.500002,7.0E-4 - 8.35E-4,0.0008,0.0,0.0,0,0,finmb_279150,Other OTC,"Igene Biotechnology, Inc.",USD,2503955,6955294,0.00049999997,2.5,2.0E-4 - 0.0025,-0.0018,-0.72,0.0002,0.0025,USD,False,False,us_market,0.0007,1630512221,-0.000100000005,0.0008,0.000835,0.0007,2956000,PRE,IGENE BIOTECHNOLOGY INC,PNK,-0.002,0,-0.003,0.0006936111,6.388873e-06,0.00921103,0.000817972,-0.00011797203,-0.14422502,1095780,-0.23333332,15,America/New_York,EDT,-14400000,4,1.98,,,0.0025,0.0002,0.0007,0.0008,2.5M,6.96M,1.57B,,,0.00%,0.47%,,,,,,,4.10%,,,,,,,,,"Dec 30, 2009","Sep 29, 2010",0.00%,"-12,422.32%",-8.21%,,4.8k,0.00,,1.02M,-426.98k,-2.37M,-0.0020,,269.29k,0,363.87k,,1.15,-0.00,-1.68M,-442.78k,Value,21045,Basic Materials,18,"Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.",Columbia,410-997-2599,MD,United States,http://www.igene.com,86400,9110 Red Branch Road,410-730-0540,Agricultural Inputs,Suite J
t-1,IGNE,-4287777,1565400064,513096,,-811212,,-811212,295618,0,-126630,-126630,-682084,-2935,,,,0,0,126630,0,-684582,,-811212,-811212,226658,34466645,7816153,-4061119,1612500,3999090,15654043,-54231774,5352141,49967,5125,977381,2100138,49967,784644,2982663,1994135,363874,487638,42803.0,-7112.0,21760.0,-298814.0,-1929.0,-289773.0,45380.0,411496.0,-7461.0,,,882525,en-US,US,EQUITY,False,Delayed Quote,-12.500002,7.0E-4 - 8.35E-4,0.0008,0.0,0.0,0,0,finmb_279150,Other OTC,"Igene Biotechnology, Inc.",USD,2503955,6955294,0.00049999997,2.5,2.0E-4 - 0.0025,-0.0018,-0.72,0.0002,0.0025,USD,False,False,us_market,0.0007,1630512221,-0.000100000005,0.0008,0.000835,0.0007,2956000,PRE,IGENE BIOTECHNOLOGY INC,PNK,-0.002,0,-0.003,0.0006936111,6.388873e-06,0.00921103,0.000817972,-0.00011797203,-0.14422502,1095780,-0.23333332,15,America/New_York,EDT,-14400000,4,1.98,,,0.0025,0.0002,0.0007,0.0008,2.5M,6.96M,1.57B,,,0.00%,0.47%,,,,,,,4.10%,,,,,,,,,"Dec 30, 2009","Sep 29, 2010",0.00%,"-12,422.32%",-8.21%,,4.8k,0.00,,1.02M,-426.98k,-2.37M,-0.0020,,269.29k,0,363.87k,,1.15,-0.00,-1.68M,-442.78k,Value,21045,Basic Materials,18,"Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.",Columbia,410-997-2599,MD,United States,http://www.igene.com,86400,9110 Red Branch Road,410-730-0540,Agricultural Inputs,Suite J
t-2,IGNE,-3482335,1565400064,469710,,-549047,,-549047,208856,0,-147599,-147599,-530967,-8166,,,,0,0,147599,0,-401448,,-549047,-549047,234357,34466644,7648636,-3247978,1487784,4642933,15654043,-53420561,5345337,51896,5132,1276195,1939425,51896,815213,3588231,2279221,363874,451641,-6487.0,-7112.0,11544.0,-19027.0,-6360.0,-12667.0,45380.0,485943.0,-7461.0,,,1648806,en-US,US,EQUITY,False,Delayed Quote,-12.500002,7.0E-4 - 8.35E-4,0.0008,0.0,0.0,0,0,finmb_279150,Other OTC,"Igene Biotechnology, Inc.",USD,2503955,6955294,0.00049999997,2.5,2.0E-4 - 0.0025,-0.0018,-0.72,0.0002,0.0025,USD,False,False,us_market,0.0007,1630512221,-0.000100000005,0.0008,0.000835,0.0007,2956000,PRE,IGENE BIOTECHNOLOGY INC,PNK,-0.002,0,-0.003,0.0006936111,6.388873e-06,0.00921103,0.000817972,-0.00011797203,-0.14422502,1095780,-0.23333332,15,America/New_York,EDT,-14400000,4,1.98,,,0.0025,0.0002,0.0007,0.0008,2.5M,6.96M,1.57B,,,0.00%,0.47%,,,,,,,4.10%,,,,,,,,,"Dec 30, 2009","Sep 29, 2010",0.00%,"-12,422.32%",-8.21%,,4.8k,0.00,,1.02M,-426.98k,-2.37M,-0.0020,,269.29k,0,363.87k,,1.15,-0.00,-1.68M,-442.78k,Value,21045,Basic Materials,18,"Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.",Columbia,410-997-2599,MD,United States,http://www.igene.com,86400,9110 Red Branch Road,410-730-0540,Agricultural Inputs,Suite J
t-3,IGNE,-2984627,1565400064,530269,,-386387,,-386387,297585,40847,-227097,-227097,-559910,-43216,,,,0,4804,231901,-36043,-159290,,-386387,-386387,242056,34466644,7261840,-2742571,1094502,4759763,15604043,-52871514,5338059,58256,5125,1295222,1559907,58256,852894,3659688,2320014,363874,465405,1557304.0,24084.0,-17441.0,-626216.0,18669.0,-668969.0,33647.0,-1898040.0,24084.0,-1.0,31673.0,2099781,en-US,US,EQUITY,False,Delayed Quote,-12.500002,7.0E-4 - 8.35E-4,0.0008,0.0,0.0,0,0,finmb_279150,Other OTC,"Igene Biotechnology, Inc.",USD,2503955,6955294,0.00049999997,2.5,2.0E-4 - 0.0025,-0.0018,-0.72,0.0002,0.0025,USD,False,False,us_market,0.0007,1630512221,-0.000100000005,0.0008,0.000835,0.0007,2956000,PRE,IGENE BIOTECHNOLOGY INC,PNK,-0.002,0,-0.003,0.0006936111,6.388873e-06,0.00921103,0.000817972,-0.00011797203,-0.14422502,1095780,-0.23333332,15,America/New_York,EDT,-14400000,4,1.98,,,0.0025,0.0002,0.0007,0.0008,2.5M,6.96M,1.57B,,,0.00%,0.47%,,,,,,,4.10%,,,,,,,,,"Dec 30, 2009","Sep 29, 2010",0.00%,"-12,422.32%",-8.21%,,4.8k,0.00,,1.02M,-426.98k,-2.37M,-0.0020,,269.29k,0,363.87k,,1.15,-0.00,-1.68M,-442.78k,Value,21045,Basic Materials,18,"Igene Biotechnology, Inc. focuses on the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company supplies natural astaxanthin, a nutrient used as a source of pigment for coloring farmed salmon and trout species. It also supplies ingredients and finished products to the nutraceutical and feed industry. The company also provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors; and analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. The company was formerly known as IGI Biotechnology, Inc. and changed its name to IGENE Biotechnology, Inc. in April 1986. IGENE Biotechnology, Inc. was founded in 1981 and is based in Columbia, Maryland.",Columbia,410-997-2599,MD,United States,http://www.igene.com,86400,9110 Red Branch Road,410-730-0540,Agricultural Inputs,Suite J
